Skip to main content
. 2012 May 9;3(5):471–478. doi: 10.1111/j.2040-1124.2012.00217.x

Table 5. Diabetes Quality of Life questionnaire scores and type of treatment in baseline and follow up.

Scale Baseline (n =503) Follow up (n =464)
Satisfaction
 Medication* 2.38 (0.59) 2.12 (0.84)
 Insulin 2.39 (0.56) 2.21 (0.69)
 Lifestyle modification* 2.38 (0.56) 2.17 (0.69)
 Lifestyle modification plus oral agents* 2.35 (0.62) 1.21 (0.68)
Impact
 Medication* 2.36 (0.61) 2.26 (0.63)
 Insulin 2.39 (0.59) 2.36 (0.59)
 Lifestyle modification* 2.45 (0.59) 2.25 (0.69)
 Lifestyle modification plus oral agents* 2.37 (0.63) 1.59 (0.68)
Diabetes‐related worry
 Medication 2.21 (0.70) 2.14 (0.71)
 Insulin 2.25 (0.70) 2.20 (0.72)
 Lifestyle modification* 2.29 (0.66) 2.19 (0.62)
 Lifestyle modification plus oral agents* 2.05 (0.72) 1.48 (0.77)
Social/vocational worry
 Medication 2.20 (0.86) 2.08 (0.86)
 Insulin 2.29 (0.85) 2.23 (0.86)
 Lifestyle modification* 2.38 (0.80) 2.23 (0.74)
 Lifestyle modification plus oral agents* 2.38 (0.80) 1.45 (0.81)
Total DQOL
 Medication 2.31 (0.59) 2.15 (0.58)
 Insulin 2.35 (0.58) 2.25 (0.60)
 Lifestyle modification* 2.39 (0.56) 2.21 (0.54)
 Lifestyle modification plus oral agents* 2.25 (0.61) 1.44 (0.53)

The data were adjusted for sex, educational status, age and diabetes duration. *Statistically significant according to Benjamini–Hochberg procedure. DQOL, Diabetes Quality of Life questionnaire.